High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus

References

• Suresh K, Sandhya AM. A study on glycemic, lipid and blood pressure control among type 2 diabetes patients of north Kerala, India. Indian Heart J. 2018;70:482–485. doi:10.1016/j.ihj.2017.10.00730170640
   PubMedGoogle Scholar
• Maratni NPT, Sindhughosa DA, Mardewi IGA, Manuaba IBAP, Saraswati MR. Individual lipids and lipid ratio in type-2 diabetic patients: association with glycemic control status. Recent Adv Biol Med. 2017;3:42–47. doi:10.18639/RABM.2017.03.455029
   Google Scholar
• Ginsberg HN, Elam MB, Lovato LC, et al. ACCORD study group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1563–1574. doi:10.1056/NEJMoa100128220228404
   PubMed Web of Science ®Google Scholar
• Rosediani M, Azidah AK, Mafauzy M. Correlation between fasting plasma glucose, post prandial glucoseand glycated haemoglobin and fructosamine. Med J Malaysia. 2006;61:67–71.16708736
   PubMedGoogle Scholar
• Mahato RV, Gyawali P, Raut PP, Regmi P, Singh KP, Gyawali P. Association between glycemic control and serum lipid profile in type 2 diabetes patients: glycated haemoglobin as a dual biomarkers. Biomed Res. 2011;22(3):375–380.
   Google Scholar
• Jaiswal M, Schinske A, Busui RP. Lipids and lipid management in diabetes. Best Pract Res Clin Endocrinol Metab. 2014;28(3):325–328. doi:10.1016/j.beem.2013.12.00124840262
   PubMed Web of Science ®Google Scholar
• Awadalla H, Noor SK, Elmadhoun WM, et al. Comparison of serum lipid profile in type 2 diabetes with and without adequate diabetes control in Sudanese population in north Sudah. Diabetes Metab Syndr. 2018;12(6):961–964. doi:10.1016/j.dsx.2018.06.00429954711
   PubMed Web of Science ®Google Scholar
• Catapano AL, Graham L, Backer GD, et al. ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;2016(37):2999–3058. doi:10.1093/eurheartj/ehw272
   Web of Science ®Google Scholar
• Katz LEL, Bacha F, Gidding SS, et al. Lipid profiles, inflammatory markers, and insulin therapy in youth with type 2 diabetes. J Pediatr. 2018;196:208–216. doi:10.1016/j.jpeds.2017.12.05229398050
   PubMed Web of Science ®Google Scholar
• Noor SK, Elmadhoun WM, Bushara SO, Almobarak AO, Salim RS, Forawi SA. Glycemic control in Sudanese individuals with type 2 diabetes: population based study. Diabetes Metab Syndr. 2017;11:S147–S151. doi:10.1016/j.dsx.2016.12.02428034691
   PubMed Web of Science ®Google Scholar
• Lin D, Qi Y, Huang C, et al. Association of lipid parameters with insulin resistance and diabetes: a population-based study. Clin Nutr. 2018;37:1423–1429. doi:10.1016/j.clnu.2017.06.01828673690
   PubMed Web of Science ®Google Scholar
• Longo-Mbenza B, Mvindu HN, Jbk O, et al. The deleterious effects of physical inactivity on elements of insulin resistance and metabolic syndrome in Central Africans at high cardiovascular risk. Diabetes Metab Syndr. 2011;5:1–6. doi:10.1016/j.dsx.2010.05.00122814833
   PubMedGoogle Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:s62–s69. doi:10.2337/dc10-S06220042775
   PubMed Web of Science ®Google Scholar
• Khan AH. Clinical significance of HBA1c as marker of circulating lipids in male and female type 2 diabetic patients. Acta Diabetol. 2007;44:193–200. doi:10.1007/s00592-007-0003-x17786383
   PubMed Web of Science ®Google Scholar
• Turner RC, Millns H, Neil HAW; for the United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non–insulin dependent diabetes mellitus: United Kingdom prospective diabetes study. Bmj. 1998;316:823–828. doi:10.1136/bmj.316.7125.899549452
   PubMed Web of Science ®Google Scholar
• Dixon JL, Stoops JD, Parker JL, et al. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol. 1999;19(12):298192. doi:10.1161/01.ATV.19.12.2981
   Web of Science ®Google Scholar
• Reaven P, Merat S, Casanada F, et al. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 1997;17(10):2250–2256. doi:10.1161/01.ATV.17.10.22509351397
   PubMed Web of Science ®Google Scholar
• Fox CS, Coady S, Sorlie PD, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the framingham heart study. Circulation. 2007;115:1544–1550. doi:10.1161/CIRCULATIONAHA.106.65894817353438
   PubMed Web of Science ®Google Scholar
• Deedwania P, Barter P, Carmena R, et al. Treating to new targets investigators. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the treating to new targets study. Lancet. 2006;368:919–928. doi:10.1016/S0140-6736(06)69292-116962881
   PubMed Web of Science ®Google Scholar
• Aguilar D, Fisher MR, O’Connor CM, et al. Investigators in the weekly intervention with zithromax for atherosclerosis and its related disorder study. Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. Am Heart J. 2006;152(2):298–304. doi:10.1016/j.ahj.2005.11.01116875914
   PubMedGoogle Scholar
• Unnikrishnan R, Anjana RM, Deepa M, et al. Glycemic control among individuals with self reported diabetes in India-The ICMR-INDIAB study. Diabetes Technol Ther. 2014;16:596–603. doi:10.1089/dia.2014.001825101698
   PubMed Web of Science ®Google Scholar
• Kisa K, Tojo T, Hatakeyama Y, Kameda R, Hashikata T, Yamaoka-Tojo M. Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide. Cardiovasc Diabetol. 2012;11(1):79. doi:10.1186/1475-2840-11-7922748110
   PubMedGoogle Scholar
• Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States. N Engl J Med. 2014;370:1514–1523. doi:10.1056/NEJMoa131079924738668
   PubMed Web of Science ®Google Scholar
• Regmi P, Gyawali P, Shrestha R, Sigdel M, Mehta KD, Majhi S. Pattern of dyslipidemia in type 2 diabetic subjects in Eastern Nepal. Jnamls. 2009;10:11–13.
   Google Scholar
• Khan AH, Sobki SH, Khan SA. Association between glycemic control and serum lipids profile in type 2 diabetic patients: HBA1c predict dyslipidaemia. Clin Exp Med. 2007;7:24–29. doi:10.1007/s10238-007-0121-317380302
   PubMed Web of Science ®Google Scholar